Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.

BACKGROUND: Post-transplantation lymphoproliferative disorders are serious complications of organ transplantation which treatment is not yet standardized. OBJECTIVE: To describe the clinical response, overall and graft survival of patients in our center with this complication after kidney transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto-Rios, John Fredy, Gómez de los Ríos, Sandra Milena, Serna-Higuita, Lina María, Ocampo-Kohn, Catalina, Aristizabal-Alzate, Arbey, Gálvez-Cárdenas, Kenny Mauricio, Zuluaga-Valencia, Gustavo Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad del Valle 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335860/
https://www.ncbi.nlm.nih.gov/pubmed/28293043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335860/
https://www.ncbi.nlm.nih.gov/pubmed/28293043

Ejemplares similares